Get App Open
In App
Credit Cards
Open App
you are here:

Nippon India Pharma Fund - Growth

  • Regular
  • Direct
Category : Sectoral/Thematic
  • NAV
    : ₹ 503.7065 -0.49%
    (as on 08th October, 2025)
Crisil Rating

Not Rated

Rank not available for the fund
Risk-O-Meter
Very High Risk

The fund has 99.46% investment in domestic equities of which 33.55% is in Large Cap stocks, 23.33% is in Mid Cap stocks, 11.26% in Small Cap stocks.

Suitable For : Investors who have advanced knowledge of macro trends and prefer to take selective bets for higher returns compared to other Equity funds. At the same time, these investors should also be ready for possibility of moderate to high losses in their investments even though overall market is performing better.

This Scheme
VS
  • Benchmark
    BSE Healthcare TRI
  • NA
  • NA
  • Gold
Compare with
  • Date : -
  • NAV : -
  • Date : -
  • Investment : -
  • Value on selected date : -
  • Returns Calculator
  • SIP Calculator
  • VIP (Value Avg)
Amount
  • Investment Date
  • Sell Date
  • Investment Value
    -
  • Sell Value
    -
  • Profit/Loss
    -
  • Annualised Returns
    -
  • Date : -
  • Investment : -
  • Value on selected date : -

Returns (NAV as on 08th October, 2025)

Period Invested for ₹10000 Invested on Latest Value Absolute Returns Annualised Returns Category Avg Rank within Category
1 Week 01-Oct-25 10050.20 0.50% - 1.92% 140/239
1 Month 08-Sep-25 9838.10 -1.62% - 1.37% 223/243
3 Month 08-Jul-25 9726.50 -2.74% - 0.17% 191/236
6 Month 08-Apr-25 10782.50 7.83% - 17.33% 216/231
YTD 01-Jan-25 9515.20 -4.85% - 2.62% 187/220
1 Year 08-Oct-24 9676.50 -3.24% -3.23% 0.43% 113/201
2 Year 06-Oct-23 14465.30 44.65% 20.18% 18.61% 58/158
3 Year 07-Oct-22 17572.20 75.72% 20.63% 19.14% 44/134
5 Year 08-Oct-20 21302.20 113.02% 16.32% 22.34% 90/109
10 Year 08-Oct-15 32379.30 223.79% 12.46% 14.02% 65/83
Since Inception 05-Jun-04 503706.50 4937.07% 20.14% 12.13% 28/217

SIP Returns (NAV as on 08th October, 2025)

Period Invested for ₹1000 SIP Started on Investments Latest Value Absolute Returns Annualised Returns
1 Year 08-Oct-24 12000 12068.71 0.57 % 1.06 %
2 Year 06-Oct-23 24000 26428.62 10.12 % 9.55 %
3 Year 07-Oct-22 36000 46928.72 30.36 % 17.98 %
5 Year 08-Oct-20 60000 90673.32 51.12 % 16.52 %
10 Year 08-Oct-15 120000 298706.42 148.92 % 17.36 %
 

Tax Treatment

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.

Portfolio (Updated on 31st Aug,2025)

Portfolio Turnover Ratio : 14.00%  |   Category average turnover ratio is 154.05%  
Fund manager updated portfolio less frequently than peers in last 1 year. (I.e. fund manager held stocks/bonds in the portfolio for longer duration than peers)
Equity Holding : 99.46% | F&O Holdings : 0.00%| Foreign Equity Holdings : 0.00%| Total : 99.46%
No of Stocks : 37 (Category Avg - 44.44) | Large Cap Investments : 33.55%| Mid Cap Investments : 23.33% | Small Cap Investments : 11.26% | Other : 31.32%

Top 10 Stocks in Portfolio

How to read this table?
Stock Invested in Sector Value(Mn) % of Total Holdings 1M Change 1Y Highest Holding 1Y Lowest Holding Quantity 1M Change in Qty
Sun Pharmaceutical Industries Ltd. Pharmaceuticals 9975.8 11.94% -0.28% 14.41% (Sep 2024) 11.94% (Aug 2025) 62.56 L 0.00
Divis Laboratories Ltd. Pharmaceuticals 6131.7 7.34% -0.21% 9.65% (Nov 2024) 7.34% (Aug 2025) 10.00 L 0.00
Cipla Ltd. Pharmaceuticals 5086.1 6.09% 0.40% 6.09% (Aug 2025) 5.32% (Dec 2024) 32.00 L 0.00
Lupin Ltd. Pharmaceuticals 5085.9 6.09% 0.16% 8.47% (Dec 2024) 5.82% (May 2025) 26.84 L 0.00
Apollo Hospitals Enterprises Ltd. Hospital 4937.3 5.91% 0.34% 5.91% (Aug 2025) 5.13% (Nov 2024) 6.49 L 0.00
Dr. Reddys Laboratories Ltd. Pharmaceuticals 4934.7 5.90% 0.21% 5.9% (Aug 2025) 5.1% (Nov 2024) 39.16 L 0.00
Medplus Health Services Ltd. Pharmacy retail 3054 3.65% -0.21% 4.2% (May 2025) 2.35% (Sep 2024) 36.27 L 0.00
Vijaya Diagnostic Centre Ltd. Healthcare service provider 2909.2 3.48% -0.07% 4.09% (Nov 2024) 3.24% (May 2025) 28.87 L 0.00
GlaxoSmithKline Pharmaceuticals Ltd. Pharmaceuticals 2543.3 3.04% -0.27% 3.73% (May 2025) 2.02% (Jan 2025) 9.13 L 0.00
Gland Pharma Ltd. Pharmaceuticals 2471.4 2.96% -0.16% 3.27% (Jun 2025) 2.59% (Apr 2025) 13.21 L 0.00
- indicates change in weight in the portfolio. # indicates a new entry.
Name Type of Instrument Weight (%)
TREPS TREPS 0.41%
Net Receivables Net Receivables 0.13%
Margin Margin 0.00%

Risk Ratios

Ratios calculated on daily returns for last 3 years (Updated as on 30th September, 2025)

  • Standard Deviation

    Low volatility
    11.44vs12.57
    Category Avg
  • Beta

    Low volatility
    0.58vs0.86
    Category Avg
  • Sharpe Ratio

    Better risk adjusted returns
    1.21vs1.01
    Category Avg
  • Treynor's Ratio

    Better risk adjusted returns
    0.24vs0.18
    Category Avg
  • Jensen's Alpha

    Better risk adjusted returns
    9.04vs3.66
    Category Avg

Alternative Funds (Category Peers)

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
Nippon India Taiwan Equity Fund - Regular Plan - Growth NA 389.09 3.20 25.53 101.25 45.50 36.08
Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth NA 249.75 3.11 10.46 34.96 28.21 18.62
Franklin Asian Equity Fund - Growth NA 259.99 7.09 12.44 32.58 16.62 14.16
Nippon India Japan Equity Fund - Growth NA 283.56 0.80 11.19 26.63 16.17 18.08
Nippon India US Equity Opportunities Fund - Growth NA 713.51 1.20 5.08 23.87 15.91 22.06
SBI Banking & Financial Services Fund - Regular Plan - Growth NA 8370.76 3.13 0.02 14.64 14.72 19.34
DSP Banking & Financial Services Fund - Regular Plan - Growth NA 1331.23 2.87 -0.36 11.82 11.57 0.00
ITI Banking and Financial Services Fund - Regular Plan - Growth NA 301.88 3.33 -1.08 10.56 11.28 13.83
WhiteOak Capital Banking & Financial Services Fund - Regular Plan - Growth NA 468.18 1.22 -0.96 12.06 10.94 0.00
Mirae Asset Banking and Financial Services Fund - Growth NA 1975.29 2.81 -1.28 12.26 10.61 18.01

More Funds from Nippon India Mutual Fund

Out of 130 mutual fund schemes offered by this AMC, 2 is/are ranked 5 * , 9 is/are ranked 4 * , 14 is/are ranked 3 * , 7 is/are ranked 2 * , 3 is/are ranked 1 * , and 95 schemes are not ranked. See more about AMC

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
Nippon India Small Cap Fund - Growth 4 64821.04 0.35 -2.60 17.65 -3.11 21.98
Nippon India ETF Nifty 50 BeES 4 49379.75 1.48 -1.07 14.23 2.49 14.43
Nippon India ETF Nifty 50 BeES 4 49379.75 1.48 -1.07 14.23 2.49 14.43
Nippon India Multicap Fund - Growth 4 46215.71 0.58 0.47 18.77 2.90 22.09
Nippon India Large Cap Fund - Growth 5 45012.18 1.14 0.80 16.60 4.62 19.71
Nippon India Growth Mid Cap Fund - Growth 4 38385.96 1.78 0.04 20.09 3.03 24.35
CPSE ETF NA 32051.91 4.58 0.16 13.18 -2.16 37.34
CPSE ETF NA 32051.91 4.55 0.13 13.11 -2.23 37.05
Nippon India Liquid Fund - Growth 2 30964.83 0.48 1.40 3.03 6.76 6.97
Nippon India Liquid Fund - Growth 2 30964.83 0.48 1.40 3.03 6.76 6.97

Forum

+ See More